Maynard Um
-
-
-
-
-
-
-
Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million
-
-
-
-
-
-
-
Gelteq reports 300% bioavailability boost in preclinical drug study
-
-
-
-
-
-
-
Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50%
-
-
-
-
-
-
-
Gelteq Limited (GELS) Receives FDA Approval of its Suitability Petition for New Animal Drug
-
-
-
-
404,872 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

